APO Research
Talk to an analyst

APO RESEARCH · REPORT

Adjuvants

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Adjuvants Market Analysis and Forecast 2026-2032

26 December 2025193 pages

Choose your research edition.

Industry ResearchAdjuvants Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Adjuvants Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Adjuvants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Adjuvants Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Adjuvants Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Adjuvants market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Adjuvants is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Adjuvants is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Adjuvants is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Adjuvants is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Adjuvants include GSK, Croda, CSL Limited, Phibro Animal Health, SDA BIO, SEPPIC, SPI Pharma, Vertellus and Huanuotai Biological, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Adjuvants, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Adjuvants, also provides the sales of main regions and countries. Of the upcoming market potential for Adjuvants, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Adjuvants sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Adjuvants market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Adjuvants sales, projected growth trends, production technology, application and end-user industry.

Adjuvants Segment by Company

GSK

Croda

CSL Limited

Phibro Animal Health

SDA BIO

SEPPIC

SPI Pharma

Vertellus

Huanuotai Biological

Rico Bio

Sanofi

Escon

Zhifei Biological

Adjuvants Segment by Type

Emulsion Adjuvants

Mineral Adjuvants

Others

Adjuvants Segment by Application

Human Vaccine

Veterinary Vaccine

Adjuvants Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adjuvants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Adjuvants in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adjuvants sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Adjuvants Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Emulsion Adjuvants Major Manufacturers Table 3. Mineral Adjuvants Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Adjuvants Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Human Vaccine Major Manufacturers Table 7. Veterinary Vaccine Major Manufacturers Table 8. Adjuvants Industry Trends Table 9. Adjuvants Industry Drivers Table 10. Adjuvants Industry Opportunities and Challenges Table 11. Adjuvants Industry Restraints Table 12. Global Adjuvants Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Adjuvants Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Adjuvants Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Adjuvants Revenue Market Share by Region (2021-2026) Table 16. Global Adjuvants Revenue Market Share by Region (2027-2032) Table 17. Global Adjuvants Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 18. Global Adjuvants Sales by Region (2021-2026) & (Tons) Table 19. Global Adjuvants Sales by Region (2027-2032) & (Tons) Table 20. Global Adjuvants Sales Market Share by Region (2021-2026) Table 21. Global Adjuvants Sales Market Share by Region (2027-2032) Table 22. Global Adjuvants Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Adjuvants Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Adjuvants Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Adjuvants Sales Market Share by Manufacturers (2021-2026) Table 26. Global Adjuvants Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 27. Global Adjuvants Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Adjuvants Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Adjuvants Manufacturers, Product Type & Application Table 30. Global Adjuvants Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Adjuvants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Adjuvants Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Adjuvants Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Adjuvants Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Adjuvants Revenue Market Share by Type (2021-2026) Table 37. Global Adjuvants Revenue Market Share by Type (2027-2032) Table 38. Global Adjuvants Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 39. Global Adjuvants Sales by Type (2021-2026) & (Tons) Table 40. Global Adjuvants Sales by Type (2027-2032) & (Tons) Table 41. Global Adjuvants Sales Market Share by Type (2021-2026) Table 42. Global Adjuvants Sales Market Share by Type (2027-2032) Table 43. Global Adjuvants Price by Type (2021-2026) & (US$/Kg) Table 44. Global Adjuvants Price by Type (2027-2032) & (US$/Kg) Table 45. Global Adjuvants Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Adjuvants Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Adjuvants Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Adjuvants Revenue Market Share by Application (2021-2026) Table 49. Global Adjuvants Revenue Market Share by Application (2027-2032) Table 50. Global Adjuvants Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 51. Global Adjuvants Sales by Application (2021-2026) & (Tons) Table 52. Global Adjuvants Sales by Application (2027-2032) & (Tons) Table 53. Global Adjuvants Sales Market Share by Application (2021-2026) Table 54. Global Adjuvants Sales Market Share by Application (2027-2032) Table 55. Global Adjuvants Price by Application (2021-2026) & (US$/Kg) Table 56. Global Adjuvants Price by Application (2027-2032) & (US$/Kg) Table 57. GSK Company Information Table 58. GSK Business Overview Table 59. GSK Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 60. GSK Adjuvants Product Portfolio Table 61. GSK Recent Development Table 62. Croda Company Information Table 63. Croda Business Overview Table 64. Croda Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 65. Croda Adjuvants Product Portfolio Table 66. Croda Recent Development Table 67. CSL Limited Company Information Table 68. CSL Limited Business Overview Table 69. CSL Limited Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 70. CSL Limited Adjuvants Product Portfolio Table 71. CSL Limited Recent Development Table 72. Phibro Animal Health Company Information Table 73. Phibro Animal Health Business Overview Table 74. Phibro Animal Health Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. Phibro Animal Health Adjuvants Product Portfolio Table 76. Phibro Animal Health Recent Development Table 77. SDA BIO Company Information Table 78. SDA BIO Business Overview Table 79. SDA BIO Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. SDA BIO Adjuvants Product Portfolio Table 81. SDA BIO Recent Development Table 82. SEPPIC Company Information Table 83. SEPPIC Business Overview Table 84. SEPPIC Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 85. SEPPIC Adjuvants Product Portfolio Table 86. SEPPIC Recent Development Table 87. SPI Pharma Company Information Table 88. SPI Pharma Business Overview Table 89. SPI Pharma Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 90. SPI Pharma Adjuvants Product Portfolio Table 91. SPI Pharma Recent Development Table 92. Vertellus Company Information Table 93. Vertellus Business Overview Table 94. Vertellus Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 95. Vertellus Adjuvants Product Portfolio Table 96. Vertellus Recent Development Table 97. Huanuotai Biological Company Information Table 98. Huanuotai Biological Business Overview Table 99. Huanuotai Biological Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 100. Huanuotai Biological Adjuvants Product Portfolio Table 101. Huanuotai Biological Recent Development Table 102. Rico Bio Company Information Table 103. Rico Bio Business Overview Table 104. Rico Bio Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 105. Rico Bio Adjuvants Product Portfolio Table 106. Rico Bio Recent Development Table 107. Sanofi Company Information Table 108. Sanofi Business Overview Table 109. Sanofi Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 110. Sanofi Adjuvants Product Portfolio Table 111. Sanofi Recent Development Table 112. Escon Company Information Table 113. Escon Business Overview Table 114. Escon Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 115. Escon Adjuvants Product Portfolio Table 116. Escon Recent Development Table 117. Zhifei Biological Company Information Table 118. Zhifei Biological Business Overview Table 119. Zhifei Biological Adjuvants Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 120. Zhifei Biological Adjuvants Product Portfolio Table 121. Zhifei Biological Recent Development Table 122. North America Adjuvants Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Adjuvants Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Adjuvants Sales by Type (2021-2026) & (Tons) Table 125. North America Adjuvants Sales by Type (2027-2032) & (Tons) Table 126. North America Adjuvants Sales Price by Type (2021-2026) & (US$/Kg) Table 127. North America Adjuvants Sales Price by Type (2027-2032) & (US$/Kg) Table 128. North America Adjuvants Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Adjuvants Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Adjuvants Sales by Application (2021-2026) & (Tons) Table 131. North America Adjuvants Sales by Application (2027-2032) & (Tons) Table 132. North America Adjuvants Sales Price by Application (2021-2026) & (US$/Kg) Table 133. North America Adjuvants Sales Price by Application (2027-2032) & (US$/Kg) Table 134. North America Adjuvants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Adjuvants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. North America Adjuvants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. North America Adjuvants Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 138. North America Adjuvants Sales by Country (2021-2026) & (Tons) Table 139. North America Adjuvants Sales by Country (2027-2032) & (Tons) Table 140. North America Adjuvants Sales Price by Country (2021-2026) & (US$/Kg) Table 141. North America Adjuvants Sales Price by Country (2027-2032) & (US$/Kg) Table 142. United States Adjuvants Revenue (2021-2032) & (US$ Million) Table 143. Canada Adjuvants Revenue (2021-2032) & (US$ Million) Table 144. Mexico Adjuvants Revenue (2021-2032) & (US$ Million) Table 145. Europe Adjuvants Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe Adjuvants Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe Adjuvants Sales by Type (2021-2026) & (Tons) Table 148. Europe Adjuvants Sales by Type (2027-2032) & (Tons) Table 149. Europe Adjuvants Sales Price by Type (2021-2026) & (US$/Kg) Table 150. Europe Adjuvants Sales Price by Type (2027-2032) & (US$/Kg) Table 151. Europe Adjuvants Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Adjuvants Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Adjuvants Sales by Application (2021-2026) & (Tons) Table 154. Europe Adjuvants Sales by Application (2027-2032) & (Tons) Table 155. Europe Adjuvants Sales Price by Application (2021-2026) & (US$/Kg) Table 156. Europe Adjuvants Sales Price by Application (2027-2032) & (US$/Kg) Table 157. Europe Adjuvants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Europe Adjuvants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Europe Adjuvants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Europe Adjuvants Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 161. Europe Adjuvants Sales by Country (2021-2026) & (Tons) Table 162. Europe Adjuvants Sales by Country (2027-2032) & (Tons) Table 163. Europe Adjuvants Sales Price by Country (2021-2026) & (US$/Kg) Table 164. Europe Adjuvants Sales Price by Country (2027-2032) & (US$/Kg) Table 165. Germany Adjuvants Revenue (2021-2032) & (US$ Million) Table 166. France Adjuvants Revenue (2021-2032) & (US$ Million) Table 167. U.K. Adjuvants Revenue (2021-2032) & (US$ Million) Table 168. Italy Adjuvants Revenue (2021-2032) & (US$ Million) Table 169. Russia Adjuvants Revenue (2021-2032) & (US$ Million) Table 170. Spain Adjuvants Revenue (2021-2032) & (US$ Million) Table 171. Netherlands Adjuvants Revenue (2021-2032) & (US$ Million) Table 172. Switzerland Adjuvants Revenue (2021-2032) & (US$ Million) Table 173. Sweden Adjuvants Revenue (2021-2032) & (US$ Million) Table 174. Poland Adjuvants Revenue (2021-2032) & (US$ Million) Table 175. China Adjuvants Revenue by Type (2021-2026) & (US$ Million) Table 176. China Adjuvants Revenue by Type (2027-2032) & (US$ Million) Table 177. China Adjuvants Sales by Type (2021-2026) & (Tons) Table 178. China Adjuvants Sales by Type (2027-2032) & (Tons) Table 179. China Adjuvants Sales Price by Type (2021-2026) & (US$/Kg) Table 180. China Adjuvants Sales Price by Type (2027-2032) & (US$/Kg) Table 181. China Adjuvants Revenue by Application (2021-2026) & (US$ Million) Table 182. China Adjuvants Revenue by Application (2027-2032) & (US$ Million) Table 183. China Adjuvants Sales by Application (2021-2026) & (Tons) Table 184. China Adjuvants Sales by Application (2027-2032) & (Tons) Table 185. China Adjuvants Sales Price by Application (2021-2026) & (US$/Kg) Table 186. China Adjuvants Sales Price by Application (2027-2032) & (US$/Kg) Table 187. Asia Adjuvants Revenue by Type (2021-2026) & (US$ Million) Table 188. Asia Adjuvants Revenue by Type (2027-2032) & (US$ Million) Table 189. Asia Adjuvants Sales by Type (2021-2026) & (Tons) Table 190. Asia Adjuvants Sales by Type (2027-2032) & (Tons) Table 191. Asia Adjuvants Sales Price by Type (2021-2026) & (US$/Kg) Table 192. Asia Adjuvants Sales Price by Type (2027-2032) & (US$/Kg) Table 193. Asia Adjuvants Revenue by Application (2021-2026) & (US$ Million) Table 194. Asia Adjuvants Revenue by Application (2027-2032) & (US$ Million) Table 195. Asia Adjuvants Sales by Application (2021-2026) & (Tons) Table 196. Asia Adjuvants Sales by Application (2027-2032) & (Tons) Table 197. Asia Adjuvants Sales Price by Application (2021-2026) & (US$/Kg) Table 198. Asia Adjuvants Sales Price by Application (2027-2032) & (US$/Kg) Table 199. Asia Adjuvants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. Asia Adjuvants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. Asia Adjuvants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. Asia Adjuvants Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 203. Asia Adjuvants Sales by Country (2021-2026) & (Tons) Table 204. Asia Adjuvants Sales by Country (2027-2032) & (Tons) Table 205. Asia Adjuvants Sales Price by Country (2021-2026) & (US$/Kg) Table 206. Asia Adjuvants Sales Price by Country (2027-2032) & (US$/Kg) Table 207. Japan Adjuvants Revenue (2021-2032) & (US$ Million) Table 208. South Korea Adjuvants Revenue (2021-2032) & (US$ Million) Table 209. India Adjuvants Revenue (2021-2032) & (US$ Million) Table 210. Australia Adjuvants Revenue (2021-2032) & (US$ Million) Table 211. Taiwan Adjuvants Revenue (2021-2032) & (US$ Million) Table 212. Southeast Asia Adjuvants Revenue (2021-2032) & (US$ Million) Table 213. SAMEA Adjuvants Revenue by Type (2021-2026) & (US$ Million) Table 214. SAMEA Adjuvants Revenue by Type (2027-2032) & (US$ Million) Table 215. SAMEA Adjuvants Sales by Type (2021-2026) & (Tons) Table 216. SAMEA Adjuvants Sales by Type (2027-2032) & (Tons) Table 217. SAMEA Adjuvants Sales Price by Type (2021-2026) & (US$/Kg) Table 218. SAMEA Adjuvants Sales Price by Type (2027-2032) & (US$/Kg) Table 219. SAMEA Adjuvants Revenue by Application (2021-2026) & (US$ Million) Table 220. SAMEA Adjuvants Revenue by Application (2027-2032) & (US$ Million) Table 221. SAMEA Adjuvants Sales by Application (2021-2026) & (Tons) Table 222. SAMEA Adjuvants Sales by Application (2027-2032) & (Tons) Table 223. SAMEA Adjuvants Sales Price by Application (2021-2026) & (US$/Kg) Table 224. SAMEA Adjuvants Sales Price by Application (2027-2032) & (US$/Kg) Table 225. SAMEA Adjuvants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. SAMEA Adjuvants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. SAMEA Adjuvants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. SAMEA Adjuvants Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 229. SAMEA Adjuvants Sales by Country (2021-2026) & (Tons) Table 230. SAMEA Adjuvants Sales by Country (2027-2032) & (Tons) Table 231. SAMEA Adjuvants Sales Price by Country (2021-2026) & (US$/Kg) Table 232. SAMEA Adjuvants Sales Price by Country (2027-2032) & (US$/Kg) Table 233. Brazil Adjuvants Revenue (2021-2032) & (US$ Million) Table 234. Argentina Adjuvants Revenue (2021-2032) & (US$ Million) Table 235. Chile Adjuvants Revenue (2021-2032) & (US$ Million) Table 236. Colombia Adjuvants Revenue (2021-2032) & (US$ Million) Table 237. Peru Adjuvants Revenue (2021-2032) & (US$ Million) Table 238. Saudi Arabia Adjuvants Revenue (2021-2032) & (US$ Million) Table 239. Israel Adjuvants Revenue (2021-2032) & (US$ Million) Table 240. UAE Adjuvants Revenue (2021-2032) & (US$ Million) Table 241. Turkey Adjuvants Revenue (2021-2032) & (US$ Million) Table 242. Iran Adjuvants Revenue (2021-2032) & (US$ Million) Table 243. Egypt Adjuvants Revenue (2021-2032) & (US$ Million) Table 244. Key Raw Materials Table 245. Raw Materials Key Suppliers Table 246. Adjuvants Distributors List Table 247. Adjuvants Customers List Table 248. Research Programs/Design for This Report Table 249. Authors List of This Report Table 250. Secondary Sources Table 251. Primary Sources List of Figures Figure 1. Adjuvants Image Figure 2. Global Adjuvants Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Adjuvants Market Size Share 2021 VS 2025 VS 2032 Figure 4. Emulsion Adjuvants Image Figure 5. Mineral Adjuvants Image Figure 6. Others Image Figure 7. Global Adjuvants Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Adjuvants Market Size Share 2021 VS 2025 VS 2032 Figure 9. Human Vaccine Image Figure 10. Veterinary Vaccine Image Figure 11. Global Adjuvants Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Adjuvants Revenue (2021-2032) & (US$ Million) Figure 13. Global Adjuvants Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Adjuvants Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Adjuvants Revenue Market Share by Region (2021-2032) Figure 16. Global Adjuvants Sales (2021-2032) & (Tons) Figure 17. Global Adjuvants Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 18. Global Adjuvants Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Adjuvants Sales YoY (2021-2032) & (Tons) Figure 20. Europe Adjuvants Sales YoY (2021-2032) & (Tons) Figure 21. China Adjuvants Sales YoY (2021-2032) & (Tons) Figure 22. Asia (Excluding China) Adjuvants Sales YoY (2021-2032) & (Tons) Figure 23. South America, Middle East and Africa Adjuvants Sales YoY (2021-2032) & (Tons) Figure 24. Global Adjuvants Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Adjuvants Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Adjuvants Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Adjuvants Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Adjuvants Revenue Market Share by Type (2021-2032) Figure 30. Global Adjuvants Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 31. Global Adjuvants Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Adjuvants Sales Market Share by Type (2021-2032) Figure 33. Global Adjuvants Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Adjuvants Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Adjuvants Revenue Market Share by Application (2021-2032) Figure 36. Global Adjuvants Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 37. Global Adjuvants Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Adjuvants Sales Market Share by Application (2021-2032) Figure 39. North America Adjuvants Revenue Share by Type (2021-2032) Figure 40. North America Adjuvants Sales Share by Type (2021-2032) Figure 41. North America Adjuvants Revenue Share by Application (2021-2032) Figure 42. North America Adjuvants Sales Share by Application (2021-2032) Figure 43. North America Adjuvants Revenue Share by Country (2021-2032) Figure 44. North America Adjuvants Sales Share by Country (2021-2032) Figure 45. Europe Adjuvants Revenue Share by Type (2021-2032) Figure 46. Europe Adjuvants Sales Share by Type (2021-2032) Figure 47. Europe Adjuvants Revenue Share by Application (2021-2032) Figure 48. Europe Adjuvants Sales Share by Application (2021-2032) Figure 49. Europe Adjuvants Revenue Share by Country (2021-2032) Figure 50. Europe Adjuvants Sales Share by Country (2021-2032) Figure 51. China Adjuvants Revenue Share by Type (2021-2032) Figure 52. China Adjuvants Sales Share by Type (2021-2032) Figure 53. China Adjuvants Revenue Share by Application (2021-2032) Figure 54. China Adjuvants Sales Share by Application (2021-2032) Figure 55. Asia Adjuvants Revenue Share by Type (2021-2032) Figure 56. Asia Adjuvants Sales Share by Type (2021-2032) Figure 57. Asia Adjuvants Revenue Share by Application (2021-2032) Figure 58. Asia Adjuvants Sales Share by Application (2021-2032) Figure 59. Asia Adjuvants Revenue Share by Country (2021-2032) Figure 60. Asia Adjuvants Sales Share by Country (2021-2032) Figure 61. SAMEA Adjuvants Revenue Share by Type (2021-2032) Figure 62. SAMEA Adjuvants Sales Share by Type (2021-2032) Figure 63. SAMEA Adjuvants Revenue Share by Application (2021-2032) Figure 64. SAMEA Adjuvants Sales Share by Application (2021-2032) Figure 65. SAMEA Adjuvants Revenue Share by Country (2021-2032) Figure 66. SAMEA Adjuvants Sales Share by Country (2021-2032) Figure 67. Adjuvants Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Adjuvants Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Emulsion Adjuvants
  • Mineral Adjuvants
  • Others
Applications
  • Human Vaccine
  • Veterinary Vaccine
Companies covered
  • GSK
  • Croda
  • CSL Limited
  • Phibro Animal Health
  • SDA BIO
  • SEPPIC
  • SPI Pharma
  • Vertellus
  • Huanuotai Biological
  • Rico Bio
  • Sanofi
  • Escon
  • Zhifei Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Adjuvants Market by Type
  3. 1.2.1 Global Adjuvants Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Emulsion Adjuvants
  5. 1.2.3 Mineral Adjuvants
  6. 1.2.4 Others
  7. 1.3 Adjuvants Market by Application
  8. 1.3.1 Global Adjuvants Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Human Vaccine
  10. 1.3.3 Veterinary Vaccine
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Adjuvants Market Dynamics
  1. 2.1 Adjuvants Industry Trends
  2. 2.2 Adjuvants Industry Drivers
  3. 2.3 Adjuvants Industry Opportunities and Challenges
  4. 2.4 Adjuvants Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Adjuvants Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Adjuvants Revenue by Region
  3. 3.2.1 Global Adjuvants Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Adjuvants Revenue by Region (2021-2026)
  5. 3.2.3 Global Adjuvants Revenue by Region (2027-2032)
  6. 3.2.4 Global Adjuvants Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Adjuvants Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Adjuvants Sales by Region
  9. 3.4.1 Global Adjuvants Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Adjuvants Sales by Region (2021-2026)
  11. 3.4.3 Global Adjuvants Sales by Region (2027-2032)
  12. 3.4.4 Global Adjuvants Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Adjuvants Revenue by Manufacturers
  2. 4.1.1 Global Adjuvants Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Adjuvants Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Adjuvants Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Adjuvants Sales by Manufacturers
  6. 4.2.1 Global Adjuvants Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Adjuvants Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Adjuvants Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Adjuvants Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Adjuvants Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Adjuvants Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Adjuvants Manufacturers, Product Type & Application
  13. 4.7 Global Adjuvants Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Adjuvants Market CR5 and HHI
  16. 4.8.2 2025 Adjuvants Tier 1, Tier 2, and Tier 3
5 Adjuvants Market by Type
  1. 5.1 Global Adjuvants Revenue by Type
  2. 5.1.1 Global Adjuvants Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Adjuvants Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Adjuvants Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Adjuvants Sales by Type
  6. 5.2.1 Global Adjuvants Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Adjuvants Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Adjuvants Sales Market Share by Type (2021-2032)
  9. 5.3 Global Adjuvants Price by Type
6 Adjuvants Market by Application
  1. 6.1 Global Adjuvants Revenue by Application
  2. 6.1.1 Global Adjuvants Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Adjuvants Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Adjuvants Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Adjuvants Sales by Application
  6. 6.2.1 Global Adjuvants Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Adjuvants Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Adjuvants Sales Market Share by Application (2021-2032)
  9. 6.3 Global Adjuvants Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Adjuvants Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 Croda
  8. 7.2.1 Croda Company Information
  9. 7.2.2 Croda Business Overview
  10. 7.2.3 Croda Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Croda Adjuvants Product Portfolio
  12. 7.2.5 Croda Recent Developments
  13. 7.3 CSL Limited
  14. 7.3.1 CSL Limited Company Information
  15. 7.3.2 CSL Limited Business Overview
  16. 7.3.3 CSL Limited Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CSL Limited Adjuvants Product Portfolio
  18. 7.3.5 CSL Limited Recent Developments
  19. 7.4 Phibro Animal Health
  20. 7.4.1 Phibro Animal Health Company Information
  21. 7.4.2 Phibro Animal Health Business Overview
  22. 7.4.3 Phibro Animal Health Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Phibro Animal Health Adjuvants Product Portfolio
  24. 7.4.5 Phibro Animal Health Recent Developments
  25. 7.5 SDA BIO
  26. 7.5.1 SDA BIO Company Information
  27. 7.5.2 SDA BIO Business Overview
  28. 7.5.3 SDA BIO Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 SDA BIO Adjuvants Product Portfolio
  30. 7.5.5 SDA BIO Recent Developments
  31. 7.6 SEPPIC
  32. 7.6.1 SEPPIC Company Information
  33. 7.6.2 SEPPIC Business Overview
  34. 7.6.3 SEPPIC Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 SEPPIC Adjuvants Product Portfolio
  36. 7.6.5 SEPPIC Recent Developments
  37. 7.7 SPI Pharma
  38. 7.7.1 SPI Pharma Company Information
  39. 7.7.2 SPI Pharma Business Overview
  40. 7.7.3 SPI Pharma Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 SPI Pharma Adjuvants Product Portfolio
  42. 7.7.5 SPI Pharma Recent Developments
  43. 7.8 Vertellus
  44. 7.8.1 Vertellus Company Information
  45. 7.8.2 Vertellus Business Overview
  46. 7.8.3 Vertellus Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Vertellus Adjuvants Product Portfolio
  48. 7.8.5 Vertellus Recent Developments
  49. 7.9 Huanuotai Biological
  50. 7.9.1 Huanuotai Biological Company Information
  51. 7.9.2 Huanuotai Biological Business Overview
  52. 7.9.3 Huanuotai Biological Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Huanuotai Biological Adjuvants Product Portfolio
  54. 7.9.5 Huanuotai Biological Recent Developments
  55. 7.10 Rico Bio
  56. 7.10.1 Rico Bio Company Information
  57. 7.10.2 Rico Bio Business Overview
  58. 7.10.3 Rico Bio Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Rico Bio Adjuvants Product Portfolio
  60. 7.10.5 Rico Bio Recent Developments
  61. 7.11 Sanofi
  62. 7.11.1 Sanofi Company Information
  63. 7.11.2 Sanofi Business Overview
  64. 7.11.3 Sanofi Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sanofi Adjuvants Product Portfolio
  66. 7.11.5 Sanofi Recent Developments
  67. 7.12 Escon
  68. 7.12.1 Escon Company Information
  69. 7.12.2 Escon Business Overview
  70. 7.12.3 Escon Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Escon Adjuvants Product Portfolio
  72. 7.12.5 Escon Recent Developments
  73. 7.13 Zhifei Biological
  74. 7.13.1 Zhifei Biological Company Information
  75. 7.13.2 Zhifei Biological Business Overview
  76. 7.13.3 Zhifei Biological Adjuvants Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Zhifei Biological Adjuvants Product Portfolio
  78. 7.13.5 Zhifei Biological Recent Developments
8 North America
  1. 8.1 North America Adjuvants Market Size by Type
  2. 8.1.1 North America Adjuvants Revenue by Type (2021-2032)
  3. 8.1.2 North America Adjuvants Sales by Type (2021-2032)
  4. 8.1.3 North America Adjuvants Price by Type (2021-2032)
  5. 8.2 North America Adjuvants Market Size by Application
  6. 8.2.1 North America Adjuvants Revenue by Application (2021-2032)
  7. 8.2.2 North America Adjuvants Sales by Application (2021-2032)
  8. 8.2.3 North America Adjuvants Price by Application (2021-2032)
  9. 8.3 North America Adjuvants Market Size by Country
  10. 8.3.1 North America Adjuvants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Adjuvants Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Adjuvants Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Adjuvants Market Size by Type
  2. 9.1.1 Europe Adjuvants Revenue by Type (2021-2032)
  3. 9.1.2 Europe Adjuvants Sales by Type (2021-2032)
  4. 9.1.3 Europe Adjuvants Price by Type (2021-2032)
  5. 9.2 Europe Adjuvants Market Size by Application
  6. 9.2.1 Europe Adjuvants Revenue by Application (2021-2032)
  7. 9.2.2 Europe Adjuvants Sales by Application (2021-2032)
  8. 9.2.3 Europe Adjuvants Price by Application (2021-2032)
  9. 9.3 Europe Adjuvants Market Size by Country
  10. 9.3.1 Europe Adjuvants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Adjuvants Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Adjuvants Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Adjuvants Market Size by Type
  2. 10.1.1 China Adjuvants Revenue by Type (2021-2032)
  3. 10.1.2 China Adjuvants Sales by Type (2021-2032)
  4. 10.1.3 China Adjuvants Price by Type (2021-2032)
  5. 10.2 China Adjuvants Market Size by Application
  6. 10.2.1 China Adjuvants Revenue by Application (2021-2032)
  7. 10.2.2 China Adjuvants Sales by Application (2021-2032)
  8. 10.2.3 China Adjuvants Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Adjuvants Market Size by Type
  2. 11.1.1 Asia Adjuvants Revenue by Type (2021-2032)
  3. 11.1.2 Asia Adjuvants Sales by Type (2021-2032)
  4. 11.1.3 Asia Adjuvants Price by Type (2021-2032)
  5. 11.2 Asia Adjuvants Market Size by Application
  6. 11.2.1 Asia Adjuvants Revenue by Application (2021-2032)
  7. 11.2.2 Asia Adjuvants Sales by Application (2021-2032)
  8. 11.2.3 Asia Adjuvants Price by Application (2021-2032)
  9. 11.3 Asia Adjuvants Market Size by Country
  10. 11.3.1 Asia Adjuvants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Adjuvants Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Adjuvants Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Adjuvants Market Size by Type
  2. 12.1.1 SAMEA Adjuvants Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Adjuvants Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Adjuvants Price by Type (2021-2032)
  5. 12.2 SAMEA Adjuvants Market Size by Application
  6. 12.2.1 SAMEA Adjuvants Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Adjuvants Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Adjuvants Price by Application (2021-2032)
  9. 12.3 SAMEA Adjuvants Market Size by Country
  10. 12.3.1 SAMEA Adjuvants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Adjuvants Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Adjuvants Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Adjuvants Value Chain Analysis
  2. 13.1.1 Adjuvants Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Adjuvants Production Mode & Process
  6. 13.2 Adjuvants Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Adjuvants Distributors
  9. 13.2.3 Adjuvants Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst